| |
Study
|
Historical control
|
Total
|
---|
Patient No
| |
23
|
29
|
52
|
Age
|
|
Median
|
66
|
60
|
63
|
|
Range
|
25–92
|
26–90
|
25–92
|
Sex
|
|
Male
|
21
|
28
|
49
|
|
Female
|
2
|
1
|
3
|
|
Squamous histology
|
22
|
30
|
52
|
Tumor sites
|
|
Oropharynx
|
5
|
10
|
15
|
|
Oral cavity
|
7
|
8
|
15
|
|
Parotid (primary or metastates)
|
3
|
1
|
4
|
|
Larynx
|
4
|
6
|
10
|
|
Hypopharynx
|
2
|
2
|
4
|
|
Unknown
|
1
|
2
|
3
|
|
Nasopharynx
|
1
|
0
|
1
|
Stages
|
|
I
|
0
|
2
|
2
|
|
II
|
2
|
1
|
3
|
|
III
|
9
|
12
|
21
|
|
IVA
|
6
|
10
|
16
|
|
IVB
|
3
|
4
|
7
|
|
IVC
|
2
|
0
|
2
|
|
Recurrence
|
1
|
0
|
1
|
T stages
|
|
Tx
|
1
|
2
|
3
|
|
T1
|
1
|
4
|
5
|
|
T2
|
13
|
10
|
23
|
|
T3
|
3
|
8
|
11
|
|
T4
|
4
|
5
|
9
|
|
Recurrence
|
1
|
0
|
1
|
Neck nodes
|
|
N0
|
3
|
8
|
11
|
|
N1
|
13
|
9
|
22
|
|
N2
|
4
|
10
|
14
|
|
N3
|
2
|
2
|
4
|
|
Recurrence
|
1
|
0
|
1
|
Treatement
|
|
Radiotherapy alone
|
5
|
5
|
10
|
|
Chemoradiation
|
18
|
24
|
42
|
- Study: Mean parotid dose constraints less than 20 Gray; Control: Mean parotid dose constraints 26 Gy.